Compromised bypass graft outcomes after minimal-incision vein harvest  by Pullatt, Rana et al.
From the Southern Association for Vascular Surgery
Compromised bypass graft outcomes after
minimal-incision vein harvest
Rana Pullatt, MD, Thomas E. Brothers, MD, Jacob G. Robison, MD, and Bruce M. Elliott, MD,
Charleston, SC
Background: Minimal incision techniques for vein harvest may lessen wound complications after lower extremity
revascularization, but long-term patency and limb salvage data are limited.
Methods: This retrospective case-control study used a computerized vascular registry set in an academic vascular surgical
practice. All patients undergoing lower extremity revascularization using autogenous reversed great saphenous vein by a
single vascular surgeon in a 10-year period were reviewed. Harvest of great saphenous vein via long single incision (SI)
in 133 patients was compared with minimal incisions with endoscopy (MIE) in 85, or MI without endoscopy in 106. The
main outcome measures were primary and secondary graft patency by Kaplan-Meier life-table analysis and cumulative
sum failure (CUSUM). Secondary outcomes of interest were limb salvage and wound complications.
Results: No differences were observed between MIE, MI, and SI patients for demographic data, risk factors, or primary
indications, including claudication, rest pain, ischemic ulcer, and gangrene. Endoscopic vein harvest patients were
significantly more likely than MI or SI to be women and more likely to use tobacco. Primary patency at 5 years was better
after SI vein harvest (59%) than with either MI (33%, P  .004) or MIE (44%, P  .045) techniques, although both MI
groups had a higher proportion of bypass grafts to the popliteal artery. Similarly, cumulative secondary patency was
better after SI (66%) than with MI (47%, P  .045), but not MIE (58%, P  .45). Differences in limb salvage at 5 years
in SI (73%) were not statistically superior to either MI (59%, P  .24) or MIE (58%, P  .13). No learning curve for MI
or MIE vein grafts was evident by CUSUM for primary patency at 12 months. No differences in wound complication
rates were observed for SI (9%), MI (10%), or MIE (6%) grafts (P  .54).
Conclusions:Graft patency and limb salvage deteriorated during the time whenMI or MIE techniques of great saphenous
vein harvest were adopted. This observation raises concern about the advisability of limiting the extent of the incision at
the potential cost of compromised outcomes without an obvious advantage in limiting wound complications. ( J Vasc
Surg 2006;44:289-95.)Vascular bypass surgery for arterial insufficiency is one
of the most common elective vascular surgery procedures
performed, and the great saphenous vein (GSV) is the most
favored conduit for use in such revascularization. Because
there is neither compelling evidence nor clear consensus of
the advantage of reversed vein over in situ techniques, the
choice remains largely one of physician preference.
Traditionally, for reversed vein grafting a long, contin-
uous incision is used to harvest the GSV. Complications
associated with this single long incision for lower extremity
or coronary bypass include edema, complex wound infec-
tion, ischemic skin flaps, pain, lymphangitis, delayed
wound healing, and fat necrosis.1-8 Wound healing com-
plication rates vary among published reports, with an inci-
dence from 9.8%, as we have previously reported, to as high
as 24%.8
It is believed that harvesting the vein by using minimal
incisions can lessen the morbidity of the procedure, espe-
cially with use of an endoscope.9-12 Reports have indicated
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doi:10.1016/j.jvs.2006.02.072that endoscopic vein harvests reduce postoperative pain,
improve patient mobility, decrease the length of hospital
stay, and reduce overall costs.9,13-17 Others have been
unable to detect differences in postoperative pain and mo-
bility between traditional and endoscopic methods.18,19
The durability of infrainguinal bypass using saphenous
vein grafts harvested endoscopically was first reported in
2001 to rival that of vein obtained by standard techniques,
with a 51% primary patency and a 68% cumulative second-
ary patency at 5 years.20 Another report confirmed a pri-
mary patency of 71% at 3 years.21 Overall, however, long-
term data on patency and limb salvage comparing minimal
incision techniques and traditional methods of harvesting
remain sparse.
METHODS
Study objectives. This retrospective study was de-
signed to compare the effects of less invasive techniques of
GSV harvest on the outcomes of lower extremity revascu-
larization. The primary outcome measures were primary
and secondary graft patency. The secondary outcome mea-
sures were limb salvage and the incidence of perioperative
wound complications. The experimental protocol was ap-
proved by the Institutional Review Board for Human Sub-
jects at the Medical University of South Carolina with
permission for exemption from written informed consent.
Case-control patient identification. All patients un-
dergoing lower extremity revascularization by a single vas-
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period were identified retrospectively by using a computer-
ized registry. Cases were limited to those of a single sur-
geon to limit the potential contribution of other confound-
ing variables in the study. The remaining vascular surgeon
authors of this study preferentially perform infrainguinal
revascularization using the in situ technique. These patients
were not included in this review.
The registry and other medical records, including inpa-
tient notes, operative reports, and clinic visits, were re-
viewed for basic patient demographic data, the indication
for operation, graft patency, and limb salvage. Incidences of
wound complications delaying recovery or requiring inter-
vention were recorded. These include Szilagyi class I, II, or
III wound infection requiring drainage or antibiotic treat-
ment (or both), lymphocele or lymphatic drainage, and
wound edge necrosis.22 Only patients undergoing lower
extremity bypass for chronic ischemia using the ipsilateral
GSV were included.
Operative techniques. The method of saphenous
vein harvest was accomplished through a single incision
(SI) over the entire length of the vein, through two ormore
minimal incisions (MI) with long intervening skin bridges
without an endoscope, or MI with an endoscope (MIE).
The skin incisions made for proximal and distal arterial
exposure were used to expose the vein for an additional 3 to
4 cm in both directions using sharp dissection and small
retractors. Additional, short 2-cm-long incisions were
made along the course of the vein to allow complete
exposure of the vein with intervening skin bridges of 6 to 8
cm long.
In situations where more than two intervening counter-
incisions would be necessary and the tissues were considered
appropriate (ie, minimal liposclerosis), theMIE approach was
used. MIE was accomplished using the Cardioversion Vein
Harvest System (EthiconEndo-Surgery, Johnson&Johnson,
Cincinnati,Ohio) and a 30° 5-mmendoscope.After the initial
dissection of the vein as described above, a dissecting trocar
was used to develop a relatively avascular plane along the top
of the vein. Carbon dioxide gas was insufflated to maintain a
working channel to facilitate dissection with endoshears and
endoclip appliers. Once removed, the vein was flushed with
heparinized (25 IU/mL) autologous blood containing pa-
paverine (1.5 mg/mL) without distending the vein. In most
instances (80%), the vein could be harvested using only the
proximal and distal skin incisions created to perform the
anastomoses.
Endoscopic techniques were not used when only one
or two counter incisions were anticipated due to the cost of
the equipment. The reversed vein was tunneled under the
sartorius muscle for femoral-popliteal bypass above the
knee or in a new subcutaneous tunnel for all other grafts
20 cm. The vein was not placed in the same tunnel from
which it was harvested. Ultrasound was not used preoper-
atively tomap the veins of any patients, regardless of harvest
technique.
Follow-up schedule. Patients were routinely pre-
scribed aspirin at 325 mg daily. Graft patency and limbsalvage were determined by physical examination and du-
plex ultrasonography at each follow-up visit. Postoperative
duplex graft surveillance was performed 3 and 12 months
after operation and annually thereafter. If surveillance iden-
tified peak systolic velocity 200 cm/s, a peak systolic
velocity ratio 3, or ankle-brachial indices worsening by
0.15, arteriography was used to confirm and delineate
grafts stenosis. Diameter reduction of 50% prompted
elective graft revision. Primary patency, cumulative second-
ary patency, and limb salvage were defined according to the
standards developed by the AdHoc Committee on Report-
ing Standards.23
Statistical analysis. Statistical analysis consisted of 2
test and Fisher’s exact test to compare proportional data.
Patency and limb salvage were analyzed by Kaplan-Meier
life tables with Yates correction. Cumulative sum failure
analysis (CUSUM) was used to detect the presence of a
learning curve.24,25 The CUSUM was defined as Sn(Xi
 Xo), where Xi 0 for continued patency/salvage and Xi
 1 for limb loss or loss of patency. The acceptable initial
clinical failure rate (Xo) of 20% at 1 year was derived from
our published experience.26,27 Although recognizing that
the failure rates deemed acceptable do vary according to
multiple patient and anatomic factors such as distal target
vessel, continued tobacco abuse, presence of tissue necro-
sis, quality of the vein, and patient gender, the small sample
size of the study necessitated use of a single average failure
estimate.
The upper 95% alarm and 80% alert boundary lines and
lower 80% reassurance lines were calculated by using an
alternative failure rate defined as twice the acceptable clin-
ical failure rate. CUSUM curves that crossing the 95% and
80% boundary lines correspond to statistically significant
differences at  error rates of 0.05 and 0.20, respectively.
RESULTS
FromMay 1995 throughMay 2005, 324 patients were
identified as undergoing revascularization using reversed
GSV by one surgeon (T. E. B.). During this interval, the
technique of reversed GSV SI harvest (n  133) was
gradually abandoned in favor of multiple limited MI (n
106) or MIE (n 85) owing to the surgeon’s conviction
that the latter techniques offered superior results (Fig 1).
When the MI or MIE techniques were used, it was never
necessary to discard a vein because of trauma nor was it
necessary to splice or reanastomose vein segments for
trauma.
Patient demographics, risk factors, and operative indi-
cations are listed in Table I. Endoscopic vein harvest pa-
tients were significantly more likely to be female and more
likely to use tobacco. Mean follow-up (mean  SD) was
longer for SI (33 35months) thanMI (18 21months)
or MIE (17 21 months) grafts. Femoral-popliteal bypass
was more commonly performed in MI and MIE than SI
patients (Table II).
Although no objective criteria for vein harvest were set
up at the outset of the experience reported, MI were more
commonly used for femoral-popliteal bypass above the
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with no more than two intervening counter incisions. On
the other hand, MIE was more typically performed for
femoral-popliteal bypass below the knee because the dis-
tance was longer. Due to the bulk of the harvesting equip-
ment and the relatively tighter, more restrictive skin condi-
tions of the lower leg above the ankle, a single long incision
was more commonly used for pedal and tibial bypass. At
Fig 1. Number of infrainguinal bypass operations using greater
saphenous vein by year. Light stippled bars indicate single incision
group, dark stippled bars indicate multiple incision without endos-
copy, and black bars indicate multiple incision with endoscopy.
Table I. Patient demographics, indications, and
operative details
Single
incision
(n  133)
(%)
Multiple incision
P
Endo
(n  85)
(%)
No endo
(n  106)
(%)
Age  SD 65  14 64  16 63  15 .95
Female gender 27 44 30 .020
African American 60 64 56 54
Risk factors
Tobacco use 40 62 39 .001
Diabetes 57 56 55 .93
Hypertension 71 82 71 .11
Renal failure 17 0 15 .66
Cardiac disease 32 38 25 .87
Indications
Claudication 5 5 8 .41
Rest pain 29 28 28 .99
Ulcer 15 16 19 .73
Gangrene 52 51 44 .22
Table II. Proximal and distal extent of bypass operation
Single
incision
(%)
Multiple incision
P
Endo
(%)
No endo
(%)
Femoropopliteal 20 32 43 .001
Femorotibial/pedal 41 51 31 .024
Popliteotibial/pedal 40 18 25 .001least half of all MIE grafts harvested used GSV from aboveand below the knee, and this was true for at least a third of
MI grafts.
Primary patency at 5 years was better after SI vein
harvest (59%) than with either MI (33%, P .004) or MIE
(44%, P  .045) techniques, even though there was a
higher proportion of bypass grafts to the popliteal artery
within both MI groups (Fig 2). Similarly, cumulative sec-
ondary patency was better after SI (66%) than with MI
(47%, P  .046), but not MIE (58%, P  .45) (Fig 3).
Differences in limb salvage at 5 years between SI (73%)
were not statistically superior to either MI (59%, P  .24)
or MIE (58%, P  .13) (Fig 4). However, the lack of
statistical significance for the inferior results in secondary
patency for MIE and in limb salvage for both MI and MIE
compared with SI may well represent type II statistical
errors for which it would take at least 200 more patients
with similar results in the MI and MIE groups to dispel.
No differences were observed between MI and MIE
patients in primary (P  .72) and cumulative secondary (P
 .32) patency and limb salvage (P .70) outcomes. Both
groups did share very common technical components, be-
cause the techniques for the initial vein dissection were
actually the same for both MIE and MI patients. Compar-
ison of outcome by the type of vein harvest according to
whether patients underwent bypass to the popliteal vs the
tibial/pedal vessels was not valid owing to the small num-
bers of patients. The results were intriguing if the MI and
MIE patients were evaluated as a single group as justified by
their shared operative components. Among pedal/tibial
bypasses, MI/MIE harvest was inferior in primary (33% vs
62%, P  .007) and secondary (45% vs 66%, P  .046)
Fig 2. Comparison of primary patency for minimal incision with
endoscopy (squares), without endoscopy (circles), and single inci-
sions (triangles). The standard errors do not exceed 10% at any
time point.patency at 5 years, but not limb salvage (53% vs 64%, P 
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differences in primary (46% vs 58%, P  .26), cumulative
secondary (66% v 66%, P  .87), and limb salvage (68% vs
75%, P .34) did not attain statistical significance, perhaps
related to even smaller sample sizes.
Overall, no differences were observed in the rate of
reintervention for compromised but patent or thrombosed
grafts (Table III). Small differences in wound complication
rates were not statistically significant. No Szilagyi class III
Fig 3. Comparison of secondary patency for minimal incision
with endoscopy (squares), without endoscopy (circles), and single
incisions (triangles). The standard errors do not exceed 10% at any
time point.
Fig 4. Comparison of limb salvage for minimal incision with
endoscopy (squares), without endoscopy (circles), and single inci-
sions (triangles). The standard errors do not exceed 10% at any
time point.infections (involving the graft) were detected.When a learning curve exists, graphic depiction of
the CUSUM score reveals a plateau.24 A declining plot
of the CUSUM represents satisfactory results compared
with the alternative clinical failure rate, and an upward-
sloping curve represents deviation towards an unaccept-
ably high rate. No learning curve for MI or MIE grafts
was evident by CUSUM for primary patency at 12
months (Fig 5).
DISCUSSION
The patient discomfort and morbidity associated with
traditional open vein harvest techniques have been the bane
of vascular bypass surgery and include leg edema and
wound breakdown.1 Less invasive surgical techniques may
lessen postoperative pain. Furthermore, with the potential
of limiting the size of the incision to disrupt fewer lym-
phatic channels, there may be less chance of postoperative
cellulitis.2 Previous studies have documented lower wound
complication rates with these techniques.9-12
Criticisms of less invasive harvest have traditionally
included increased harvest time, additional expense, and
potential vein trauma. To address these concerns, other
studies have suggested that vein harvest using an endoscope
compromises neither the histologic integrity nor the func-
tional properties of the vein.13,28-32 Nonetheless, despite
earnest efforts at careful dissection, unrecognized vein
trauma may represent one potential contributing factor to
the inferior patency and limb salvage observed in our study.
Interestingly, no learning curve was detected among
the 85 patients undergoing MIE nor among the 106 pa-
tients with MI. It is possible that the surgeon used im-
proper techniques, especially with the procedural compo-
nents common to both types of MI harvest, or that the
learning curve was much longer for this surgeon and was
never reached, or both. One possible factor in the failure to
reach the plateau of a learning curve for the 85 MIE
patients may be related to the observation that over the
course of most of the study period, MIE was only per-
formed an average of once a month. Another possibility is
that the particular MIE system used was inferior compared
with other available devices. Finally, it is possible that the
higher proportion of women and smokers in the MIE
subgroup might have disadvantaged the results of that
particular group. Of note, these gender and tobacco differ-
ences were not observed in the MI group, who also expe-
Table III. Wound complication rate and requirement for
reintervention
Single
incision
(%)
Multiple incision
P
Endo
(%)
No endo
(%)
Wound complications 9 6 10 .54
Revision patent grafts 5 7 9 .45
Revision thrombosed grafts 11 15 15 .30rienced poorer outcomes.
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compare the influence of distal graft outflow was consid-
ered reasonable for secondary analysis. This increased the
power of the study because the endoscopic technique also
used in all of the operative elements of the MI subgroup.
We believe this to be valid in that subgroup analysis showed
that the patency and limb salvage in the MI and MIE
groups did not differ. These comparisons suggested that
the inferiority of the MI harvest techniques were most
remarkable in the distal bypass grafts, although there were
still not enough patients undergoing femoropopliteal by-
pass with a SI for comparison to exclude the possibility of a
type II error.
The current study is clearly limited by its retrospective
nature, allowing for the possible introduction of selection
bias. A prospective, randomized-control study would be
required to validate our outcomes. In addition, becauseMI
and MIE techniques were more commonly used in the
Fig 5. Cumulative sum failure analysis (CUSUM) for multiple
incision technique with endoscopy (above) and without endos-
copy (below). The dashed line indicates 80% reassurance line and
the dot-dash line indicates 80% alert line and the dot-dot-dash line
indicates the 95% alarm line. (See text under Methods for further
description of these lines.)latter years, any tendency for poorer outcomes from openrevascularization, such as due to increasing use of endovas-
cular techniques for less complicated anatomic situations,
could introduce bias into the results. The year of bypass did
not, however, prove to be a predictor of graft patency or
limb salvage independent of type of harvest. No differences
were observed among groups in the primary indications for
intervention, which might have substantiated claims of
more disadvantaged anatomic situations, while data on the
number of previous interventions was not available for
analysis.
Another factor that may have had an impact on our
findings was that although grafts from the popliteal to tibial
and pedal vessels were more likely in the SI group, the fact
that such operations were performed through a single
incision could have been related to a shorter overall length
of the bypass itself. All vein grafts were used in the reversed
configuration, so no conclusions should be drawn from the
present study about the use of MI or MIE techniques
during in situ bypass.
CONCLUSION
Despite the study limitations, the observation that graft
patency and limb salvage deteriorated during the time
when MI techniques of GSV harvest were adopted raises
concern regarding the advisability of limiting the extent of
the incision at the potential cost of compromised outcomes
without an obvious advantage in limiting wound complica-
tions. Further study of this concern is warranted.
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Dr. Jordan: Dr Pullatt has summarized their single-institu-
tion experience with 324 patients over 12 years with 191 of these
procedures being done with limited incisions and endoscopic vein
harvest. Their results have identified a substantially worse graft
patency with the minimally invasive approach and NO DIFFER-
ENCE in the postoperative wound morbidity. The conclusion
seems quite contrary to the body of literature and the earlier report
from Charlottesville that has been built in favor of endoscopic vein
harvest. While your manuscript cites two papers that suggest of sub
optimal outcome in the cardiac literature, most of that cardiac
literature is more optimistic. More specifically, there has been
recent consensus statement from a Thoracic Surgery Society that
suggests that endoscopic vein harvest is a standard of care for their
patients. However, vascular surgeons approach lower extremity
disease quite differently than cardiac surgeons approach coronary
artery disease. Most particularly, longer segments of vein are
required and surveillance is done in a more systematic, reliable, and
noninvasive fashion. However, most of our cardiac surgery patients
are undergoing this limited incision surgery. Do you believe their
outcomes are sub-optimal and that they should change and go
back to the standard open incision?
Do you suspect that there is a difference in harvest technique
between the PA who does a multiple per week as opposed to the
vascular surgeon who in this series only averaged one endoscopic
vein harvest every one-month over 12 years? While three surgeons
are authors of the paper, only one surgeon adopted this technique.endoscope used is different from the one used in Charlottesville.
Do you think this could have contributed to the poorer outcomes?
Finally, you have clearly stated in your manuscript and your pre-
sentation that patency rates are suboptimal. Your argument actu-
ally suggests that we should that we should not even entertain a
randomized, prospective trial if you truly believe that it is inferior.
Do you think we should cloak these results in the mantra of the
need for randomized clinical trial or is your mind already made up
about the appropriate way to harvest these vein grafts? So tell this
audience your current clinical approach on you harvest your veins.
Dr. Brothers: Thank you, Will. I have taken the liberty of
answering the questions for Dr. Pullatt because, unlike him, I was
there for each and every procedure and I would hate to have him
take credit for these suboptimal results.
Your first question related to the use of the endoscopic harvest
in cardiac patients. I can’t really tell them what to do. You certainly
pointed out that the bypass grafts that they use are shorter. I
certainly have seen more and smaller injuries to the veins that we
harvest with this technique and perhaps, they can exclude those
portions of the vein with injuries from their interventions. You also
appropriately mentioned that their type of followup is perhaps not
as rigorous as ours and, in fact, they may have more problems than
they realize. Similarly, you pointed out that instead of the attend-
ing vascular surgeon doing the harvests, they actually had physician
assistants do that. I would hate to think that their technique is
better than mine, but that certainly is one option that I just can’t
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the residents were convinced they could do a better job.
Your final question related to whether or not we think that this
technique ought to be abandoned. I think absolutely the answer is
no. I do think it needs to be studied a little bit more carefully. As
Dr. Pullatt outlined, there are a lot of other reasons for our
worsening results, including the facts that the study was not
randomized and that there were differences in the time period
using endovascular techniques. So it may very well be that this is
simply a case of comparing apples and oranges. When we looked at
the influence of time, alone, not the type of vein harvest, we saw
some trends in terms of worsening results over time, but time reallywas not as strong of a predictor as actually the type of harvest. In
fact, in the manuscript we do support the notion of a prospective
randomized study.
Finally,with regards to the typeof the device that is used for harvest,
certainly the type of device that we used changed over time. This is a
10-year experience, and the use of carbon dioxide insufflation did be-
come more popular with time. It seemed to be a better technique, but
again I do not think that totally minimized the overall trauma. My two
partners who are authors on this paper actually preferentially use the
in-situ technique, so it was more for that reason than anything else that
they did not use endoscopic harvest. I suspect that they will continue to
use the in situ technique instead of reversing the vein.
